Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
Dana-Farber
May 31, 2024, 14:27 |
Immune Oncology
How Does Immunotherapy Work
What is immunotherapy? Immunotherapy is a type of cancer treatment that uses the power of…
May 31, 2024, 07:38 |
Societies
Join us for a summer activity that's both deliciously fun and heartwarmingly charitable - The Jimmy Fund
The Jimmy Fund recently shared on X: "Looking for a fun summer activity that's both deliciously…
May 31, 2024, 02:35 |
Blog
Biagio Ricciuti: Great conversation on the role of ICI in patients with NSCLC and driver mutations
Biagio Ricciuti shared a post by Narjust Florez on X, adding: , "I had a…
May 30, 2024, 10:18 |
Blog
It’s an uplifting day for cancer survivors! - .406 Ventures
.406 Ventures shared on LinkedIn: . "It’s an uplifting day for cancer survivors!…
May 29, 2024, 09:25 |
Insight
Biagio Ricciuti: The association of automatically extracted body composition metrics with IO efficacy in mNSCLC
Biagio Ricciuti, recently posted on X: "Out in JAMA Oncology! Our effort to determine the…
May 29, 2024, 09:10 |
Societies
Narjust Florez: I hope you are ready to shake the status quo with me at ASCO24
Narjust Florez shared a post on X: "Don’t miss our ASCO24 presentation… I hope you are…
May 29, 2024, 08:50 |
Blog
Shushan Hovsepyan: Some oral abstract sessions in pediatric oncology to keep on your radar at ASCO 2024
Shushan Hovsepyan shared a post on LinkedIn: "ASCO 2024 is just around the corner and here…
May 29, 2024, 08:20 |
Blog
Paolo Tarantino: In this work by the AZ translational team, QCS proved superior to manual IHC in predicting the activity of T-DXd
Paolo Tarantino shared a post on X: "In the ph1 trial of T-DXd in HER2-low MBC,…
May 28, 2024, 14:57 |
Blog
Narjust Florez: We don’t have to fit in anybody’s box
Narjust Florez shared a post by Dana-Farber News on X/Twitter, adding: ''Once, I was told…
May 28, 2024, 14:34 |
Drugs
Paolo Tarantino: Impressive activity with tucatinib plus trastuzumab for HER2-mutated breast cancer
Paolo Tarantino shared on X: "Impressive activity with tucatinib plus trastuzumab for HER2-mutated breast cancer.…
59
60
61
62
63
All:
961
Posts:
601 - 610
ASTRO24: 15 Posts Not To Miss From Day 4
Top 100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2024
Paper Alert! Cutaneous Metastases in Thyroid Cancer: A Comprehensive Review of 136 Cases
ASTRO 24: 15 Posts Not to Miss From Day 3
Gavin Creel: Broadway Icon Dies After Battle with Rare Sarcoma at 48
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube